Pembrolizumab,Axitinib,Sunitinib,Lenvatinib,Everolimus,nivolumab,Ipilimumab
Merck,Pfizer,eisai,BMS
['keynote426', 'key,note,42', 'nivo', 'pembro', '/ipi', 'key,note,426']
awesome and timely summary by based on the data we just heard on #keynote426 and #clear. #asco23 great data throughout. longest f/u with nivo/ipi and pembro/axi. cross-trial comparisons are always tough but the pembro/len data looking increasingly good with a 
PGY-2 @BrighamMedRes | @USJLiban MSc '16 MD '18 | @DanaFarber Research '21 | @ASCO #IMG CoP & #JCOCCI Editorial Board | Cancer Genomics |
FCOI: https://t.co/dYsEwGGqP1